NR565 WEEK6 RESPIRATORY PROTOCOL ASSIGNMENT WITH COMPLETE QUESTIONS AND ANSWERS
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
CORE DOMAINS
Asthma Pathophysiology and Classification
Asthma Assessment and Diagnostic Testing
GINA Stepwise Pharmacological Management
Asthma Exacerbation Management
COPD Pathophysiology and Pharmacotherapy
Smoking Cessation Interventions
Respiratory Drug Classes and Mechanisms
Patient Education and Inhaler Technique
Special Populations in Respiratory Care
Monitoring and Follow-Up in Respiratory Disease
INTRODUCTION
This comprehensive examination preparation resource is meticulously designed for students completing the NR565
Week 6 Respiratory Protocol Assignment at Chamberlain University. The assessment mirrors the assignment
blueprint, testing candidates on asthma pathophysiology and classification, GINA stepwise pharmacological
management, COPD pharmacotherapy, smoking cessation interventions, respiratory drug classes, patient
,education, and special population considerations. Each question demands critical thinking, clinical judgment, and
the application of evidence-based pharmacological principles to realistic respiratory care scenarios. The
examination emphasizes GINA guideline adherence, appropriate medication selection, and the professional
competencies expected of advanced pharmacology students. Candidates are expected to demonstrate mastery of
respiratory pharmacology concepts and the ability to develop comprehensive treatment protocols for patients with
asthma and COPD.
SECTION ONE
QUESTIONS 1–100
Question 1
A 28-year-old female presents with episodic wheezing, chest tightness, and shortness of breath that worsens
with exercise and at night. Her symptoms occur approximately twice per week, and she experiences nighttime
awakenings about twice per month. According to GINA guidelines, what is the most appropriate classification of
this patient's asthma?
A. Intermittent asthma
B. Mild persistent asthma
C. Moderate persistent asthma
D. Severe persistent asthma
,🟢 Correct Answer:
A
🔴 RATIONALE:
Intermittent asthma is characterized by daytime symptoms occurring 2 days per week or less and nighttime
awakenings 2 times per month or less. This patient's symptom frequency (twice weekly daytime, twice monthly
nighttime) meets the criteria for intermittent asthma classification. Mild persistent asthma would involve
symptoms more than 2 days per week but less than daily, with nighttime awakenings 3-4 times per month.
Question 2
A 45-year-old patient with asthma has daytime symptoms occurring 4 days per week and nighttime awakenings
3-4 times per month. According to GINA guidelines, this patient's asthma would be classified as:
A. Intermittent
B. Mild persistent
C. Moderate persistent
D. Severe persistent
🟢 Correct Answer:
B
🔴 RATIONALE:
, Mild persistent asthma is defined as daytime symptoms occurring more than 2 days per week but less than
daily, with nighttime awakenings 3-4 times per month. This patient's symptoms (4 days per week, 3-4 nighttime
awakenings per month) meet the criteria for mild persistent asthma.
Question 3
According to GINA guidelines, what is the preferred reliever medication for Step 1 (intermittent) asthma in
patients 12 years and older?
A. Short-acting beta-agonist (SABA) as needed
B. Low-dose ICS-formoterol as needed
C. Low-dose inhaled corticosteroid (ICS) as needed
D. Long-acting beta-agonist (LABA) as needed
🟢 Correct Answer:
B
🔴 RATIONALE:
GINA guidelines recommend low-dose ICS-formoterol as the preferred reliever for Step 1 asthma, as it reduces
the risk of severe exacerbations compared with using a SABA as a reliever. While SABA has traditionally been
used, current guidelines favor ICS-formoterol for its combined anti-inflammatory and bronchodilator effects.
ALREADY GRADED A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
CORE DOMAINS
Asthma Pathophysiology and Classification
Asthma Assessment and Diagnostic Testing
GINA Stepwise Pharmacological Management
Asthma Exacerbation Management
COPD Pathophysiology and Pharmacotherapy
Smoking Cessation Interventions
Respiratory Drug Classes and Mechanisms
Patient Education and Inhaler Technique
Special Populations in Respiratory Care
Monitoring and Follow-Up in Respiratory Disease
INTRODUCTION
This comprehensive examination preparation resource is meticulously designed for students completing the NR565
Week 6 Respiratory Protocol Assignment at Chamberlain University. The assessment mirrors the assignment
blueprint, testing candidates on asthma pathophysiology and classification, GINA stepwise pharmacological
management, COPD pharmacotherapy, smoking cessation interventions, respiratory drug classes, patient
,education, and special population considerations. Each question demands critical thinking, clinical judgment, and
the application of evidence-based pharmacological principles to realistic respiratory care scenarios. The
examination emphasizes GINA guideline adherence, appropriate medication selection, and the professional
competencies expected of advanced pharmacology students. Candidates are expected to demonstrate mastery of
respiratory pharmacology concepts and the ability to develop comprehensive treatment protocols for patients with
asthma and COPD.
SECTION ONE
QUESTIONS 1–100
Question 1
A 28-year-old female presents with episodic wheezing, chest tightness, and shortness of breath that worsens
with exercise and at night. Her symptoms occur approximately twice per week, and she experiences nighttime
awakenings about twice per month. According to GINA guidelines, what is the most appropriate classification of
this patient's asthma?
A. Intermittent asthma
B. Mild persistent asthma
C. Moderate persistent asthma
D. Severe persistent asthma
,🟢 Correct Answer:
A
🔴 RATIONALE:
Intermittent asthma is characterized by daytime symptoms occurring 2 days per week or less and nighttime
awakenings 2 times per month or less. This patient's symptom frequency (twice weekly daytime, twice monthly
nighttime) meets the criteria for intermittent asthma classification. Mild persistent asthma would involve
symptoms more than 2 days per week but less than daily, with nighttime awakenings 3-4 times per month.
Question 2
A 45-year-old patient with asthma has daytime symptoms occurring 4 days per week and nighttime awakenings
3-4 times per month. According to GINA guidelines, this patient's asthma would be classified as:
A. Intermittent
B. Mild persistent
C. Moderate persistent
D. Severe persistent
🟢 Correct Answer:
B
🔴 RATIONALE:
, Mild persistent asthma is defined as daytime symptoms occurring more than 2 days per week but less than
daily, with nighttime awakenings 3-4 times per month. This patient's symptoms (4 days per week, 3-4 nighttime
awakenings per month) meet the criteria for mild persistent asthma.
Question 3
According to GINA guidelines, what is the preferred reliever medication for Step 1 (intermittent) asthma in
patients 12 years and older?
A. Short-acting beta-agonist (SABA) as needed
B. Low-dose ICS-formoterol as needed
C. Low-dose inhaled corticosteroid (ICS) as needed
D. Long-acting beta-agonist (LABA) as needed
🟢 Correct Answer:
B
🔴 RATIONALE:
GINA guidelines recommend low-dose ICS-formoterol as the preferred reliever for Step 1 asthma, as it reduces
the risk of severe exacerbations compared with using a SABA as a reliever. While SABA has traditionally been
used, current guidelines favor ICS-formoterol for its combined anti-inflammatory and bronchodilator effects.
